IRON — Disc Medicine Inc. stock price and chart

Share this page

IRON

$56.84+0.34%

as of close, Oct 16, 2026

☾ AH $56.84 +0.34%

Disc Medicine Inc.Stock · HealthcareRussell 2000 0.07%Nasdaq Composite 0.008%Russell 3000 0.003%US Stock Market 0.003%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

Available history since Aug 17, 2020

VolumeSEEEE

20202022202320252026

50.0100.0150.0200.0250.0300.0350.0400.0450.0500.005.0M$56.84

2026-10-16

Price$56.84

MA20$72.02

MA50$69.92

Vol560.6K

What would $1,000 invested in IRON be worth today? →

IRON returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $56.84
YTD price return: -28.42%
YTD total return: -28.42%
Next earnings: Nov 5, 2026
Market cap: 2.2B2020-12 14.2B2026-10 2.2B-84.6% over the window
Enterprise value: 1.5B
Shares outstanding: 38.4M2020-12 43M2026-06 38.4M-10.7% over the window
52W low: $40.00
52W high: $99.50
From 52W high: -42.87%
From 52W low: +42.10%
52W range: 28%

Volume

Rel volume: 0.91×
30D volume: 617.4K
30D $ vol: 40.3M

Fundamentals

EPS (ttm): -$6.562021-06 -$1.392026-06 -$6.56+371.9% over the window
FCF (ttm): -197.6M2020-12 -32.7M2026-06 -197.6M+503.7% over the window
FCF/share: -$5.152020-12 -$0.762026-06 -$5.15+576.1% over the window
Book value/share: $16.782020-09 -$0.192026-06 $16.78-8815.2% over the window
ROE: -38.17%2021-06 -37.9%2026-06 -38.2%+0.6% over the window
ROA: -33.45%2020-12 -490.9%2026-06 -33.5%-93.2% over the window
Debt / equity: 0.09×2023-12 0.002026-06 0.09
Current ratio: 24.142020-09 2.912026-06 24.14+729.4% over the window

Growth (CAGR, ttm) · 10Y

Shares: +10.44%2025-06-30 → 2026-06-3034.8M → 38.4M (+10.4% total)+18.83%2023-06-30 → 2026-06-3022.9M → 38.4M (+67.8% total)-2.29%2021-06-30 → 2026-06-3043.1M → 38.4M (-10.9% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Book value/share: -5.03%2025-06-30 → 2026-06-30$17.67 → $16.78 (-5.0% total)+1.12%2023-06-30 → 2026-06-30$16.23 → $16.78 (+3.4% total)+35.62%2021-06-30 → 2026-06-30$3.66 → $16.78 (+358.7% total)n/a
Price: -23.58%2025-10-16 → 2026-10-16$74.36 → $56.84 (-23.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+6.57%2023-10-16 → 2026-10-16$46.96 → $56.84 (+21.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-12.62%2021-10-15 → 2026-10-16$111.60 → $56.84 (-49.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a
Total return: -23.58%2025-10-16 → 2026-10-16$74.36 → $56.84 (-23.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+6.57%2023-10-16 → 2026-10-16$46.96 → $56.84 (+21.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-12.62%2021-10-15 → 2026-10-16$111.60 → $56.84 (-49.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -8.7×2020-12 -347.472026-10 -8.89-97.4% over the window
Fwd P/E: -8.8×
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 3.4×2020-12 -492.542026-10 3.39-100.7% over the window
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: -9.05%2020-12 -0.2%2026-06 -7.0%+2950.5% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 38.4M ÷ 34.8M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -10.44%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-10.44%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1.8B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -10.44%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($2.2B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2020-12 -0.1%2026-06 0.0%-100.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($2.2B). Same caveat as the cash buyback yield.: 0.00%2020-12 -0.1%2026-06 0.0%-100.0% over the window

Vs own 10Y history

P/B: 42nd

Bar = where today’s multiple sits in IRON’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

+0.34%

-8.41%

-17.11%

-22.64%

YTD

-28.42%

-23.56%

-49.07%

Financial statements

Open full IRON financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

IRON — Disc Medicine Inc. price, chart and key statistics